Skip to main content

Table 2 CAM Use Within the Last 12 Months

From: Prevalence and predictors of complementary and alternative medicine use among people with coronary heart disease or at risk for this in the sixth Tromsø study: a comparative analysis using protection motivation theory

 

CHD (N = 830)

No CHD but family risk (N = 4830)

No CHD nor family risk (N = 5443)

P-value*

% (n)

% (n)

% (n)

CAM provider

9.4 (88)

12.8 (663)

11.6 (672)

0.007

OTC CAM products

20.8 (189)

25.4 (1273)

21.3 (1217)

<0.001

CAM self-care approaches

1.6 (15)

5.2 (261)

5.5 (314)

<0.001

Over all CAM use

30.2 (251)

35.8 (1730)

32.1 (1749)

<0.001

  1. *Pearson’s Chi-square test